Amgen acquires stake in BeiGene to expand cancer drug business to China
RUBY WALLAU FOR STAT
For BeiGene, the partnership bolsters its existing commercial operations in China, which already sells certain cancer medicines owned by Celgene.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario